Royal Bank of Canada’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-416
| Closed | -$1K | – | 6466 |
|
|
2024
Q2 | $1K | Buy |
416
+64
| +18% | +$154 | ﹤0.01% | 6407 |
|
|
2024
Q1 | $1K | Buy |
352
+22
| +7% | +$62 | ﹤0.01% | 6322 |
|
|
2023
Q4 | $1K | Sell |
330
-582
| -64% | -$1.76K | ﹤0.01% | 6365 |
|
|
2023
Q3 | $3K | Buy |
912
+73
| +9% | +$240 | ﹤0.01% | 6211 |
|
|
2023
Q2 | $3K | Buy |
839
+838
| +83,800% | +$3K | ﹤0.01% | 6318 |
|
|
2023
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6700 |
|
|
2022
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6806 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6990 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6924 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 7257 |
|
|
2021
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 7117 |
|
|
2021
Q3 | $0 | Sell |
1
-243
| -100% | – | ﹤0.01% | 7109 |
|
|
2021
Q2 | $19K | Buy |
244
+144
| +144% | +$11.2K | ﹤0.01% | 6081 |
|
|
2021
Q1 | $5K | Sell |
100
-32
| -24% | -$1.6K | ﹤0.01% | 6533 |
|
|
2020
Q4 | $8K | Buy |
132
+127
| +2,540% | +$7.7K | ﹤0.01% | 5915 |
|
|
2020
Q3 | $1K | Hold |
5
| – | – | ﹤0.01% | 5913 |
|
|
2020
Q2 | $0 | Sell |
5
-24
| -83% | – | ﹤0.01% | 6157 |
|
|
2020
Q1 | $1K | Buy |
29
+25
| +625% | +$862 | ﹤0.01% | 5908 |
|
|
2019
Q4 | $0 | Sell |
4
-6
| -60% | – | ﹤0.01% | 6216 |
|
|
2019
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 5610 |
|
|
2019
Q2 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 5606 |
|